Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

574

HTML

4600

Tables (1-3)

135

Sum=5309

Mar 28, 2011 (publication date) through Jan 20, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Mar 28, 2011; 17(12): 1531-1537
Published online Mar 28, 2011. doi: 10.3748/wjg.v17.i12.1531

Table 2 Chemotherapy and reactivation of hepatitis B

Classes	Drugs
Alkylating agents	Cyclophosphamide, chlorambucil, cisplatin
Alkaloids	Vincristine, vinblastine
Antibiotics	Doxorubicin, epirubicin, daunorubicin, bleomycin, mitomycin C, actinomycin D
Antimetabolites	Cytarabine, fluorouracil, gemcitabine, mercaptopurine, methotrexate, thioguanine
Monoclonal antibodies	Rituximab (anti-CD20), alemtuzumab (anti-CD52)
Corticosteroids	Dexamethasone, methylprednisolone, prednisone
Others	Folinic acid, colaspase, docetaxel, etoposide, fludarabine, interferon, procarbazine

Citation: Manzano-Alonso ML, Castellano-Tortajada G. Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy. World J Gastroenterol 2011; 17(12): 1531-1537
URL: https://www.wjgnet.com/1007-9327/full/v17/i12/1531.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i12.1531